Avalo Therapeutics Correlations
AVTX Stock | USD 10.13 0.48 4.97% |
The current 90-days correlation between Avalo Therapeutics and Aerovate Therapeutics is -0.04 (i.e., Good diversification). The correlation of Avalo Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Avalo Therapeutics Correlation With Market
Good diversification
The correlation between Avalo Therapeutics and DJI is -0.05 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Avalo Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Avalo |
Moving together with Avalo Stock
0.61 | MLYS | Mineralys Therapeutics, | PairCorr |
0.64 | BAC | Bank of America Fiscal Year End 10th of January 2025 | PairCorr |
0.72 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
0.61 | INTC | Intel Fiscal Year End 23rd of January 2025 | PairCorr |
Moving against Avalo Stock
0.79 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.76 | MTEM | Molecular Templates | PairCorr |
0.71 | NKTX | Nkarta Inc | PairCorr |
0.67 | AGL | agilon health | PairCorr |
0.65 | TPST | Tempest Therapeutics | PairCorr |
0.63 | ME | 23Andme Holding | PairCorr |
0.61 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
0.55 | IPSC | Century Therapeutics | PairCorr |
0.54 | VALN | Valneva SE ADR | PairCorr |
0.53 | A | Agilent Technologies Earnings Call Tomorrow | PairCorr |
0.46 | PFE | Pfizer Inc Aggressive Push | PairCorr |
0.45 | BACK | IMAC Holdings | PairCorr |
0.45 | CYRX | Cryoport | PairCorr |
0.35 | TCHH | Trustcash Holdings | PairCorr |
0.31 | ROIV | Roivant Sciences | PairCorr |
0.78 | EC | Ecopetrol SA ADR | PairCorr |
0.76 | KO | Coca Cola Aggressive Push | PairCorr |
0.72 | HYMTF | Hyundai Motor | PairCorr |
0.71 | PG | Procter Gamble | PairCorr |
0.67 | TLK | Telkom Indonesia Tbk | PairCorr |
0.57 | SHG | Shinhan Financial | PairCorr |
0.51 | WF | Woori Financial Group | PairCorr |
0.5 | BA | Boeing Fiscal Year End 29th of January 2025 | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Avalo Stock performing well and Avalo Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Avalo Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ANAB | 3.29 | (1.01) | 0.00 | (0.21) | 0.00 | 5.30 | 35.57 | |||
ACLX | 2.46 | 0.23 | 0.12 | 0.22 | 2.74 | 6.28 | 15.13 | |||
GPCR | 2.96 | (0.25) | 0.00 | (0.24) | 0.00 | 8.18 | 24.50 | |||
AVTE | 2.55 | 0.49 | 0.19 | 0.61 | 2.13 | 5.58 | 19.11 | |||
ALXO | 3.50 | (0.92) | 0.00 | (0.31) | 0.00 | 7.53 | 22.71 | |||
ANEB | 5.20 | (0.27) | 0.00 | (0.03) | 0.00 | 8.85 | 76.00 | |||
ACRV | 2.84 | (0.57) | 0.00 | (0.20) | 0.00 | 7.66 | 22.84 | |||
PMVP | 1.67 | 0.02 | (0.03) | 0.28 | 2.12 | 3.75 | 13.98 | |||
MOLN | 4.66 | (0.26) | 0.00 | (0.11) | 0.00 | 9.61 | 52.92 | |||
MLYS | 2.68 | (0.08) | 0.03 | 0.09 | 3.37 | 6.27 | 20.98 |
Avalo Therapeutics Corporate Management
Blake MD | Scientific Advisor | Profile | |
Barbara Slusher | Founder Board | Profile | |
Maxim CFA | VP Relations | Profile | |
Stephen Thomas | VP Discovery | Profile | |
Christopher Sullivan | Chief Officer | Profile |